Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via Google Scholar Articles by Cully, J. A. Articles by Petersen, L. A. Search for Related Content PubMed Citation Articles by Cully, J. A. Articles by Petersen, L. A. Veterans Costs, Cost Analysis Depression Quality of Care, Practice Guidelines Antidepressants Related Articles

Quality of Depression Care and Its Impact on Health Service Use and Mortality Among Veterans

The authors are affiliated with the Houston Veterans Affairs (VA) Health Services Research and Development Center of Excellence and the Michael E. DeBakey VA Medical Center, Houston. Dr. Cully is also affiliated with the Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston. Dr. Petersen is also affiliated with the Department of Medicine, Baylor College of Medicine. Send correspondence to Dr. Cully at VAMC, 2002 Holcombe Blvd. (152), Houston, TX 77030 (e-mail: jcully{at}bcm.edu).

OBJECTIVE: Little is known about the effects of quality of depression care on patient outcomes other than depression status. This study examined Veterans Health Administration (VHA) data over a six-year period to determine whether quality of depression care was related to patients' health service use and mortality. METHODS: Using a national VHA database, the authors identified 205,165 veterans with a new-onset depressive disorder and at least one filled prescription for an antidepressant medication between October 1, 1999, and September 30, 2005. Quality of depression care was assessed with antidepressant medication possession ratios and adequacy of follow-up care (three or more depression-related visits during the 84 days after a depression diagnosis). Logistic regression modeling was used to predict inpatient service use and all-cause mortality. RESULTS: Of the cohort 48% received an adequate supply of antidepressant medication and 31% had three or more follow-up visits during the 84-day profiling period. Rates of adequate medication supply did not change over the six-year period, but there were improvements in adequate follow-up care over the study period (p=.03). Adequate follow-up depression care was associated with increased health service use and decreased likelihood of 12-month all-cause mortality. CONCLUSIONS: According to the quality indicators, less than half of patients with newly diagnosed depression received high-quality care. Notably, adequate follow-up care for depression was significantly related to reduction in odds of patient mortality at the 12-month follow-up. These findings suggest that quality of depression care may significantly affect patient outcomes, including mortality, and that further efforts to improve quality appear warranted.

Related Articles:

Complacent Care and the Quality Gap

Greer Sullivan
Psychiatr Serv 2008 59: 1367. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2008 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us